about
RETRACTED: Gut microbiota and pediatric disease.Efficacy and tolerability of α-galactosidase in treating gas-related symptoms in children: a randomized, double-blind, placebo controlled trial.Adherent-invasive Escherichia coli (AIEC) in pediatric Crohn's disease patients: phenotypic and genetic pathogenic features.Extradigestive manifestations of IBD in pediatrics.Investigation of small bowel in pediatric Crohn's disease.Inflammatory Bowel Disease-Unclassified in Children: Diagnosis and Pharmacological Management.Clinical Features and Risk Factors of Autoimmune Liver Involvement in Pediatric Inflammatory Bowel Disease.Prospective Evaluation of the Achievement of Mucosal Healing with Anti-TNF-α Therapy in a Paediatric Crohn's Disease Cohort.Aortic Intima-Media Thickness as an Early Marker of Atherosclerosis in Children With Inflammatory Bowel Disease.Paediatric ulcerative colitis surgery: Italian survey.Managing paediatric acute severe ulcerative colitis according to the 2011 ECCO-ESPGHAN guidelines: Efficacy of infliximab as a rescue therapy.Clostridium difficile and pediatric inflammatory bowel disease: a prospective, comparative, multicenter, ESPGHAN study.Malignancy and mortality in pediatric patients with inflammatory bowel disease: a multinational study from the porto pediatric IBD group.Intestinal lymphoid nodular hyperplasia in children: the relationship to food allergy.Human herpes virus-6 chromosomal integration misled the management of Crohn's disease.Mapping histologic patchiness of celiac disease by push enteroscopy.Biological therapy in a pediatric Crohn disease population at a referral center.Pneumatic balloon dilation in pediatric achalasia: efficacy and factors predicting outcome at a single tertiary pediatric gastroenterology center.Natural history of pancreatic involvement in paediatric inflammatory bowel disease.Narrow band imaging combined with water immersion technique in the diagnosis of celiac disease.RETRACTED: Interactions between intestinal microbiota and innate immune system in pediatric inflammatory bowel disease.Effect of Early Versus Late Azathioprine Therapy in Pediatric Ulcerative Colitis.Ultrasonography of the colon in pediatric ulcerative colitis: a prospective, blind, comparative study with colonoscopy.First Identification of Biallelic Inherited DUOX2 Inactivating Mutations as a Cause of Very Early Onset Inflammatory Bowel Disease.Phenotype and disease course of early-onset pediatric inflammatory bowel diseaseMagnetic resonance enterography, small-intestine contrast US, and capsule endoscopy to evaluate the small bowel in pediatric Crohn's disease: a prospective, blinded, comparison studyA Treat to Target Strategy Using Pan-Enteric Capsule Endoscopy in Pediatric Patients With Crohn's DiseasePredicting the Durability of Biological Therapy in Pediatric Crohn’s Disease: Do the Immunomodulators Matter?Autoimmune Enteropathy in a 13-Year-Old Celiac Girl Successfully Treated With InfliximabDisease course and efficacy of medical therapy in stricturing paediatric Crohn's diseasePresenting features and disease course of pediatric ulcerative colitisSmall Intestine Contrast Ultrasonography in Pediatric Crohn's DiseaseDrug DevelopmentUsefulness of single-balloon enteroscopy in pediatric Crohn's diseaseRole of Gastroesophageal Reflux in Children With Unexplained Chronic CoughMethotrexate in paediatric ulcerative colitis: a retrospective survey at a single tertiary referral centreNon-acid gastro-oesophageal reflux in children with suspected pulmonary aspiration[Are new medications able to modify the natural history of intestinal inflammatory diseases?]Treatment Options and Outcomes of Pediatric IBDU Compared with Other IBD Subtypes: A Retrospective Multicenter Study from the IBD Porto Group of ESPGHANPrimary Sclerosing Cholangitis in Children With Inflammatory Bowel Diseases Is Associated With Milder Clinical Activity But More Frequent Subclinical Inflammation and Growth Impairment
P50
Q27691431-4D3BD1CD-0A48-46E4-B862-7CDD1F481D87Q33459323-945585E8-53CF-4064-87EB-A41C59EA6DB6Q34410373-7011CD4E-0BC7-4808-8056-089635FC81B7Q37520951-23F02E65-BD8E-4E80-8CA0-14E30DACB2A5Q37978594-2D7A3D8A-D777-4BE0-8642-1DDCC00020B9Q38985144-AD1EAFD8-2CD0-498C-8D3C-7D909D21B295Q40117892-AA5203AA-AB7B-4E2D-8A08-5AC4B2303F22Q40721934-D28E5540-A5C5-495D-A545-90853A8D2B09Q40873120-99FB5579-0D05-4253-B418-FB22DCB6298CQ41037342-9F59F54D-F1EE-4233-B809-448C0239C2FAQ41317089-7BAF2A35-0F02-4523-857A-AA45FAF190D2Q41721641-4E44457A-A91E-4CDB-A5E9-26156717AB9BQ42234869-58203E47-FD04-492D-95B3-BE800A76CCFFQ43988052-7234AE89-4E8D-4914-9BCC-4C47A86B5572Q45365924-51F6108E-DE5D-4A1D-913C-AAD7FEDBBFCEQ46040425-8912E342-8D51-4717-A890-701E9D005E37Q46933432-176B79C2-72B2-4AA0-A530-D5E515EEC19BQ48136339-D2EC54EB-B1D5-42B2-A39A-4E4A47A527C2Q51052848-E5C64F3F-C88E-42EE-8F74-9BC332E86226Q51053458-27921502-E40E-4A6F-803A-578448DD8B7CQ52629486-D2E6FFA7-19CE-4795-A0B4-F61AAA5A04E3Q53062022-0E189AD4-D9F6-416C-9EA7-A97134706B41Q54291259-6520A4E6-3E9D-4CC5-B621-DFAC2E3B36E7Q54413653-DAA65E10-A525-4FF9-BF05-671F3CC50419Q56974890-689B3908-4025-4A31-AA5A-E4B9EA35D005Q57107964-1636762E-D388-4751-BAA0-C8A76D2929DAQ57468273-11FB41DC-C43C-46A8-B3E2-5B71FC50DA8DQ57803834-4DEDE99C-FEE1-421C-B245-B0CB8AAE9D87Q57803848-985CCB21-8789-48F7-99C7-75AE672BC685Q57803974-9031E7CD-5129-47F1-B3FA-DADAB5679507Q57803999-B8784D17-A363-4CF9-BD5B-D5BC77118A2EQ57804005-C2D9F9D9-6A2B-4812-98B0-315C5CC1BC71Q57804033-DA3F67DB-7483-4461-B5FC-123A5A0B5BBCQ57804089-172DD0F0-1A53-447C-A8AB-43BBD49AA31AQ57804132-EBA75EE9-5290-49B0-8C2D-419A95BF8201Q57804187-8D40EC9B-3930-4F5C-90CF-BDCBA5049EDAQ57804195-397A842C-30E5-4D09-97D9-8376E94BD548Q84946781-BBE7A8B5-DAA7-46BA-B1B5-2658E18601EFQ89348544-5B3C060F-6A16-4798-8B1B-03DE8AA18ECEQ93166615-A815D509-7AEB-4B33-8B6D-35264C1CDCE7
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Marina Aloi
@en
Marina Aloi
@nl
type
label
Marina Aloi
@en
Marina Aloi
@nl
prefLabel
Marina Aloi
@en
Marina Aloi
@nl
P31
P496
0000-0001-7404-4004